Developing a constipation therapy that doesn’t cause harmful side effects has been challenging for researchers. Complicating the matter is that each person’s gut microbiome – the community of bacteria inside their digestive system – is unique. As a result, the few constipation therapies that are available work for some, but not for others.
Research from Purna Kashyap, M.B.B.S., associate director of the Center for Individualized Medicine Microbiome Program, finds genetically engineered bacteria hold promise for a new constipation treatment with potentially fewer side effects.
Read more here.
Join the conversation
Learn more about the latest clinical applications of precision medicine at this year’s Individualizing Medicine Conference. It will be held Sept. 12-13, 2018.